The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Malygin V.L.

Kafedra psikhologicheskogo konsul'tirovaniia, psikhokorrektsii i psikhoterapii Moskovskogo gosudarstvennogo mediko-stomatologicheskogo universiteta

Boĭko A.N.

KGBUZ "Krasnoiarskiĭ kraevoĭ Tsentr po profilaktike i bor'be so SPID i infektsionnymi zabolevaniiami"

Konovalova O.E.

Interregional Department of Multiple Sclerosis at Moscow Clinical Hospital №24, Moscow, Russia;
Pirogov Russian National Research Medical University, Moscow, Russia

Iskandirova A.S.

Dumbrova E.V.

Evdokimov Moscow State University of Medical Dentistry, Moscow, Russia

Boĭko O.V.

Moskovskiĭ gorodskoĭ tsentr rasseiannogo skleroza na baze Gorodskoĭ klinicheskoĭ bol'nitsy #11

Malygin Ya.V.

Pirogov Russian National Research Medical University, Moscow

Influence of psychopathological factors and personality traits on the results of the study of quality of life in patients with multiple sclerosis

Authors:

Malygin V.L., Boĭko A.N., Konovalova O.E., Iskandirova A.S., Dumbrova E.V., Boĭko O.V., Malygin Ya.V.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2019;119(2‑2): 42‑48

DOI: 10.17116/jnevro20191192242

Views: 1066

Downloaded: 21

Download PDF (RU)
Contact the author
Table of contents

INFLUENCE OF PSYCHOPATHOLOGICAL FACTORS AND PERSONALITY TRAITS ON THE RESULTS OF THE STUDY OF QUALITY OF LIFE IN PATIENTS WITH MULTIPLE SCLEROSIS
INFLUENCE OF PSYCHOPATHOLOGICAL FACTORS AND PERSONALITY TRAITS ON THE RESULTS OF THE STUDY OF QUALITY OF LIFE IN PATIENTS WITH MULTIPLE SCLEROSIS

To cite this article:

Malygin VL, Boĭko AN, Konovalova OE, Iskandirova AS, Dumbrova EV, Boĭko OV, Malygin YaV. Influence of psychopathological factors and personality traits on the results of the study of quality of life in patients with multiple sclerosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2019;119(2‑2):42‑48. (In Russ.)
https://doi.org/10.17116/jnevro20191192242

Подписка 2025-2 (S.S. Korsakov Journal of Neurology and Psychiatry (special issues))
 
МСФ на ЯМ
Close metadata
Recommended articles:
Biobanking in clinical trials invo­lving multiple scle­rosis patients. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(7-2):7-15
The diagnostic effe­ctiveness of criteria for neuromyelitis optica spectrum diso­rders in the Russian clinical practice. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(7-2):16-25
Adhe­rence to treatment in the mana­gement of patients with multiple scle­rosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(7-2):26-32
A role of cere­brovascular diseases in the progression of multiple scle­rosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(5):53-57
Exploring the feasibility of pero­ral endo­scopic myotomy for stage IV esophageal acha­lasia patients. Russian Journal of Evidence-Based Gastroenterology. 2024;(2):5-13
Opti­cal cohe­rence tomo­graphy in the diagnosis of multiple scle­rosis. Russian Annals of Ophthalmology. 2024;(3):59-68
Questionnaires for arm function asse­ssment in patients with multiple scle­rosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(6):36-42
Features of primary forms of headache in multiple scle­rosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(6):70-73
Neurofilament light chain: a diagnostic pote­ntial for multiple scle­rosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(6):115-119
To study the effe­ctiveness and impact on the quality of life of patients with subclinical and clinically pronounced anxiety diso­rder of a mobile application in combination with Adaptol therapy. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(7):98-105

Objective. To study the influence of psychopathological factors and personality traits on the results of the study of quality of life (QoL) in patients with multiple sclerosis (MS). Material and methods. Forty-three patients with relapsing MS were included in the study (74.4% female; mean age 33.1 years). SF-36 was used to evaluate QoL. Effects of psychopathological factors, cognitive regulation of emotions and personality traits on QoL were studied. Statistical analysis was performed using multiple linear model. Results and discussion. A wide number of strategies of cognitive regulation of emotions has conflicting effects on the physical component of QoL; subscales of anhedonic depression and anxious arousal (MASQ), which probably represent depressive and anxiety disorders, decrease the physical component of QoL. The key factors of the mental component of QoL include psychopathological factors (mostly obsessive-compulsive symptoms) and personality traits (the more intense they are the lower is QoL). Strategies of cognitive regulation of emotions have low impact on the mental component of QoL.

Keywords:

multiple sclerosis
quality of life
coping-strategies

Authors:

Malygin V.L.

Kafedra psikhologicheskogo konsul'tirovaniia, psikhokorrektsii i psikhoterapii Moskovskogo gosudarstvennogo mediko-stomatologicheskogo universiteta

Boĭko A.N.

KGBUZ "Krasnoiarskiĭ kraevoĭ Tsentr po profilaktike i bor'be so SPID i infektsionnymi zabolevaniiami"

Konovalova O.E.

Interregional Department of Multiple Sclerosis at Moscow Clinical Hospital №24, Moscow, Russia;
Pirogov Russian National Research Medical University, Moscow, Russia

Iskandirova A.S.

Dumbrova E.V.

Evdokimov Moscow State University of Medical Dentistry, Moscow, Russia

Boĭko O.V.

Moskovskiĭ gorodskoĭ tsentr rasseiannogo skleroza na baze Gorodskoĭ klinicheskoĭ bol'nitsy #11

Malygin Ya.V.

Pirogov Russian National Research Medical University, Moscow

List of references:

  1. Lavallee DC, Chenok KE, Love RM, Petersen C, Holve E, Segal CD, Franklin PD. Incorporating patient-reported outcomes into health care to engage patients and enhance care. Health Aff. 2016;35(4):575-582. https://doi.org/10.1377/hlthaff.2015.1362
  2. World Health Organisation. Neurological disorders: public health challenges. Switzerland: World Health Organisation; 2006.
  3. Lee Mortensen G, Rasmussen PV. The impact of quality of life on treatment preferences in multiple sclerosis patients. Patient Prefer Adherence. 2017;11:1789-1796. https://doi.org/10.2147/PPA.S142373
  4. Salhofer-Polanyi S, Friedrich F, Löffler S, Rommer PS, Gleiss A, Engelmaier R, Leutmezer F, Vyssoki B. Health-related quality of life in multiple sclerosis: temperament outweighs EDSS. BMC Psychiatry. 2018;18:143. https://doi.org/10.1186/s12888-018-1719-6
  5. Fiest KM, Greenfield J, Metz LM, Patten SB, Jetté N, Marrie RA. Discriminative ability of quality of life measures in multiple sclerosis. Health Qual Life Outcomes. 2017;15(1):246.
  6. Boĭko OV. Quality of life studies in multiple sclerosis patients. Zhurnal Nevrologii i Psikhiatrii im. S.S. Korsakova. 2014;114(10):105-113. (In Russ.)
  7. Boyko OV, Tatarinova MY, Popova EV, Guseva MR, Boyko AN, Gusev EI. The improvement of quality of life of patients with multiple sclerosis over 15-year period. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2018;118(8-2):23-28. (In Russ.) https://doi.org/10.17116/jnevro201811808223
  8. Patten SB, Marrie RA, Carta MG Depression in multiple sclerosis. Int Rev Psychiatry. 2017;29(5):463-472. https://doi.org/10.1080/09540261.2017.1322555
  9. Popova EV. Factors determining quality of life in patients with remitting multiple sclerosis. Zhurnal Nevrologii i Psikhiatrii im. S.S. Korsakova. 2008;108(4):77-80. (In Russ.)
  10. Lebedeva AV, Shchukin IA, Soldatov MA, Boĭko OV, Petrov SV, Khozova AA, Ismailov AM, Shikhkerimov RK, Boĭko AN. Asthenia, emotional disorders and quality of life of patients with multiple sclerosis. Zhurnal Nevrologii i Psikhiatrii im. S.S. Korsakova. 2014;114(10-2):99-104. (In Russ.)
  11. Nourbakhsh B, Julian L, Waubant E. Fatigue and depression predict quality of life in patients with early multiple sclerosis: a longitudinal study. Eur J Neurol. 2016;23(9):1482-1486. https://doi.org/10.1111/ene.13102
  12. Dibrivnaia KA, Enikolopova EV, Zubkova IuV, Boĭko AN. Characteristics of coping strategies in patients with multiple sclerosis. Zhurnal Nevrologii i Psikhiatrii im. S.S. Korsakova. 2013;113(2-2):48-52. (In Russ.)
  13. Nikolaev EL, Vasilieva NV, Golenkova AV. Clinico-psychological peculiarities if coping strategies in multiple sclerosis patients. Praticheskaya Medicina. 2015;5(90):59-62. (In Russ.)
  14. Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, Fujihara K, Havrdova E, Hutchinson M, Kappos L, Lublin FD, Montalban X, O’Connor P, Sandberg-Wollheim M, Thompson AJ, Waubant E, Weinshenker B, Wolinsky JS. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol. 2011;69(2):292-302. https://doi.org/10.1002/ana.22366
  15. Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G, Correale J, Fazekas F, Filippi M, Freedman MS, Fujihara K, Galetta SL, Hartung HP, Kappos L, Lublin FD, Marrie RA, Miller AE, Miller DH, Montalban X, Mowry EM, Sorensen PS, Tintoré M, Traboulsee AL, Trojano M, Uitdehaag BMJ, Vukusic S, Waubant E, Weinshenker BG, Reingold SC, Cohen JA. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2017;17(2):167. https://doi.org/10.1016/S1474-4422(17)30470-2
  16. Lublin FD, Reingold SC, Cohen JA, Cutter GR, Sørensen PS, Thompson AJ, Wolinsky JS, Balcer LJ, Banwell B, Barkhof F, Bebo B Jr, Calabresi PA, Clanet M, Comi G, Fox RJ, Freedman MS, Goodman AD, Inglese M, Kappos L, Kieseier BC, Lincoln JA, Lubetzki C, Miller AE, Montalban X, O’Connor PW, Petkau J, Pozzilli C, Rudick RA, Sormani MP, Stüve O, Waubant E, Polman CH Defining the clinical course of multiple sclerosis: the 2013 revisions. Neurology. 2014;83(3):278-286. https://doi.org/10.1212/WNL.0000000000000560
  17. Malygin YaV. Klinicheskie varianty i terapiya rasstroistv so stertymi sochetannymi trevozhno-depressivnymi proyavleniyami: Dis... kand. med. nauk. M. 2009. (In Russ.)
  18. Rasskazova EI, Leonova AB, Pluzhnikov IV. Razrabotka russkoyazychnoi versii oprosnika kognitivnoi regulyatsii emotsii. Vestnik Moskovskogo Universiteta. 2011;14(4):161-179. (In Russ.)
  19. Montel S, Spitz E, Bungener C. Coping strategies in multiple sclerosis patients with frontal cognitive disorders. Eur Neurol. 2012;68(2):84-88. https://doi.org/10.1159/000337905
  20. Malygin VL, Ogarev VV, Iskandirova AS, Pakhtusova EE, Merkur’eva YuA, Malygin YaV. Psikhologicheskaya korrektsiya nizkoi motivatsii k lecheniyu bol’nykh virusnym gepatitom S. Uchebno-metodicheskoe posobie. M.: FGBOU VO MGMSU im. A.I. Evdokimova MZ RF; 2018. (In Russ.)
  21. Hasselmann H, Bellmann-Strobl J, Ricken R, Oberwahrenbrock T, Rose M, Otte C, Adli M, Paul F, Brandt AU, Finke C, Gold SM. Characterizing the phenotype of multiple sclerosis-associated depression in comparison with idiopathic major depression. Mult Scler. 2016;22(11):1476-1484. https://doi.org/10.1177/1352458515622826
  22. Fernández O, Baumstarck-Barrau K, Simeoni MC, Auquier P; MusiQoL study group. Patient characteristics and determinants of quality of life in an international population with multiple sclerosis: assessment using the MusiQoL and SF-36 questionnaires. Mult Scler. 2011;17(10):1238-1249. https://doi.org/10.1177/1352458511407951
  23. Tatarinova MIu, Fokin IV, Boĭko AN. Quality of life in multiple sclerosis and pharmaco-economic studies. Zhurnal Nevrologii i Psikhiatrii im. S.S. Korsakova. 2002;102:2(2):76-80. (In Russ.)
  24. Freeman JA, Hobart JC, Thompson AJ. Does adding MS-specific items to a generic measure (the SF-36) improve measurement? Neurology. 2001;57(1):68-74.
  25. Popova EV, Riabukhina OV, Vorob’eva OV, Malkova NA, Boĭko AN. Changes in quality of life in patients with remitted multiple sclerosis during the specific treatment with disease-modifying drugs: a comparative study of populations of Moscow and Novosibirsk. Zhurnal Nevrologii i Psikhiatrii im. S.S. Korsakova. 2010;110(5-1):67-70. (In Russ.)
  26. Achiron A, Aref H, Inshasi J, Harb M, Alroughani R, Bijarnia M, Cooke K, Yuksel O. Effectiveness, safety and health-related quality of life of multiple sclerosis patients treated with fingolimod: results from a 12-month, real-world, observational PERFORMS study in the Middle East. BMC Neurol. 2017;17:150. https://doi.org/10.1186/s12883-017-0913-3
  27. Foley JF, Nair KV, Vollmer T, Stephenson JJ, Niecko T, Agarwal SS, Watson C. Long-term natalizumab treatment is associated with sustained improvements in quality of life in patients with multiple sclerosis. Patient Prefer Adherence. 2017;11:1035-1048. https://doi.org/10.2147/PPA.S134865
  28. Boyko OV, Boyko AN, Guseva MR. Changes in quality of life of MS patients under natalizumab therapy. Nevrologich Z. 2018;1:42-46. (In Russ.) https://doi.org/10.18821/1560-9545-2018-23-1
  29. Lobentanz IS, Asenbaum S, Vass K, Sauter C, Klösch G, Kollegger H, Kristoferitsch W, Zeitlhofer J. Factors influencing quality of life in multiple sclerosis patients: disability, depressive mood, fatigue and sleep quality. Acta Neur Scand. 2004;110(1):6-13.
  30. Lysandropoulos AP, Havrdova E; ParadigMS Group. ‘Hidden’ factors influencing quality of life in patients with multiple sclerosis. Eur J Neurol. 2015;22(suppl 2):28-33. https://doi.org/10.1111/ene.12801

Close metadata

Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.